Medicine Grand Rounds: COVID-19

Covid-19 Clinical Issues

The Duke Department of Medicine is uniquely poised to address compelling clinical issues that will directly affect patient care in the coming weeks. Medicine faculty include world leaders in COVID-related clinical and research topics as well as in medical education, and many of them are already preparing talks or discussion points on these topics for their peers and collaborators across the country.

We asked these faculty to create focused 20-minute presentations for a revamped online Medicine Grand Rounds starting April 10, 2020. Join us for a Zoom Webinar each Friday at 8 a.m. for these presentations and Q&A discussion.

The schedule below will be updated regularly with speaker information.

How to attend

Faculty and trainees are asked to register once for the series; you will receive the Zoom virtual conference information in an email. (The email will include a link that is unique to you and cannot be forwarded to others to use.)


The new Medicine Grand Rounds COVID-19 clinical talks will take place each Friday at 8 a.m. virtually through Zoom.

Date and Time Presenter Title
4/10/20 at 8 a.m.

Tara Spector, MD (General Internal Medicine)

Rebekah Moehring, MD (Infectious Diseases)

The Duke COVID-19 Clinical Experience: Lessons Learned

Duke COVID-19 Treatment Algorithms

Watch recording of talk here. 

4/17/20 at 8 a.m.

Jonathan Fischer, MD (Hospice and Palliative Care Medicine)

Kathryn Pollak, PhD (Population Health Sciences)

Lawrence Mumm, MD (General Internal Medicine

*Discussion moderated by David Casarett, MD, Chief of Palliative Care

Palliative Care in Times of COVID-19

Watch recording of talk here. 

4/24/20 at 8 a.m.

John Bonnewell, MD (Fellow, Infectious Diseases)

Christopher Polage, MD (Pathology) 

Plasma Therapy for COVID-19

Laboratory testing for COVID-19 at Duke

Watch recording of talk here. 

5/1/20 at 8 a.m.

Pulmonary, Allergy, and Critical Care Medicine:

*Discussion moderated by Neil MacIntyre, MD 

Duke COVID-19 Challenges from the Intensivists' Perspective

Watch recording of talk here. 

5/8/20 at 8 a.m.

Michael Gunn, MD (Cardiology)

Terri Tarrant, MD (Rheumatology and Immunology)

Mehri McKellar, MD (Infectious Diseases)

Immunomodulation of SARS-CoV-2-Induced Inflammation: Trials and Tribulations​

Watch recording of talk here.

5/15/20 at 8 a.m.

Manesh Patel, MD (Cardiology)

Christopher Granger, MD (Cardiology)

Rahul Loungani, MD (Fellow, Cardiovascular Disease)

COVID-19: Implications for Cardiovascular Health

Watch recording of talk here. 

5/22/20 No COVID conference  
5/29/20 at 8 a.m.
  • Alex Cho, MD MBA – Clinical Director, DUMC Telehealth Office
  • Donna Phinney, MSN, RN– Director, DUHS Telehealth Office
  • Matt Roman, MHA, MMCI – Chief Digital Strategy Officer, DUHS
  • Blake Cameron, MD, MBI – Co-Medical Director for Clinical Access, Department of Medicine

*Moderated by Ziad Gellad, MD MPH, Associate Vice Chair, Ambulatory Practice, Department of Medicine

COVID-19 and the Telehealth Transformation at Duke

Watch recording of talk here.

CME credit

Medicine Grand Rounds - COVID-19 clinical talks has been approved for 1.0 credits of continuing medical education. Attendees will mark attendance by texting a code to be provided during the webinar and will be associated with appropriate CME credit* provided to the Duke Continuing Medical Education office.

In support of improving patient care, the Duke University Health System Department of Clinical Education & Professional Development is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the health care team.

Unapproved Use Disclosure: Duke School of Medicine requires CME faculty (speakers) to disclose to the attendees 1) when products or procedures being discussed are off label, unlabeled, experimental, and or investigational (not FDA approved); and 2) any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and or unsupported opinion. Faculty at this event may discuss information about pharmaceutical agents that is outside of the US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education, and is not intended to promote off label use of these medications. If you have any questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.

Credit Designation: Duke University Health System Department of Clinical Education and Professional Development designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit. Physicians should claim only credit commensurate with the extent of their participation in the activity.